A New Trend to Introduce a Biocompatible Drug Carrier Based on Immunoglobulin for Prolonged Release of Palladium (II) Complex as an Anticancer Agent: Drug Release and Cytotoxicity Assessment
- 24 March 2025
- journal article
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (4)
Abstract
Severe side effects and low chemotherapy efficacy remain challenges in cancer treatment. Therefore, this research is aimed at investigating a colloidal drug nanocarrier based on immunoglobulin nanoparticles (IgGNPs) for sustained release of an anticancer agent. A novel palladium (II) complex (PBD) loaded to IgGNPs and its formation (PBD@IgGNP) was characterized by FTIR, DLS, and AFM techniques. The size of designed system was 797 ± 121 nm, with a particle size distribution and surface charge greater than those of IgGNP indicating the conjugation of PBD and IgGNP. The release behavior indicated that 33.66% of PBD and 12.76% of encapsulated PBD in IgGNP were released at 579 h, while carboplatin was completely released at 216 h. The release mechanism followed Korsmeyer–Peppas model and non‐Fickian law. Other kinetic parameters of the release are also presented. Furthermore, MTT assay showed that IC50 values of PBD and PBD@IgGNP on breast cancer cells, 4T1, were 0.75 mM while 78% of the cells were viable at the same concentration of carboplatin. DAPI, AO/EB, and PCR staining indicated that the apoptotic induction of PBD@IgGNP was greater than PBD. Moreover, in vivo results confirmed the apoptotic induction and inhibition of tumor growth in the presence of PBD@IgGNP. These valuable achievements proposed a potential nanocarrier to increase the apoptotic induction and effectiveness of anticancer drugs and decrease their side effects.Keywords
Funding Information
- Shahid Beheshti University of Medical Sciences
This publication has 29 references indexed in Scilit:
- Comparison of In Vitro and In Vivo Biological Screening of Nano‐Palladium (II) and Platinum (II)‐Based Compounds With DFT and Molecular Docking StudyApplied Organometallic Chemistry, 2024
- Biomedical potential of nanozymes: Harnessing redox enzyme mimicry for theranostic applicationsCoordination Chemistry Reviews, 2024
- Green synthesis of Zn nanoparticles and in situ hybridized with BSA nanoparticles for Baicalein targeted delivery mediated with glutamate receptors to U87‐MG cancer cell linesApplied Organometallic Chemistry, 2022
- Bovine Serum Albumin Nanoparticles for the Efficient Delivery of Berberine: Preparation, Characterization and In vitro biological studiesColloids and Surfaces A: Physicochemical and Engineering Aspects, 2021
- Inhibition of glucuronomannan hexamer on the proliferation of lung cancer through binding with immunoglobulin GCarbohydrate Polymers, 2020
- Increasing the effectiveness of oxaliplatin using colloidal immunoglobulin G nanoparticles: Synthesis, cytotoxicity, interaction, and release studiesColloids and Surfaces B: Biointerfaces, 2020
- Interaction between immunoglobulin G and peroxidase-like iron oxide nanoparticles: Physicochemical and structural features of the proteinBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2020
- Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin deliveryInternational Journal of Biological Macromolecules, 2018
- Influence of graphene-oxide nanosheets impregnation on properties of sterculia gum-polyacrylamide hydrogel formed by radiation induced polymerizationInternational Journal of Biological Macromolecules, 2017
- Antibody‐Mediated Drug Delivery Systems2012